Novo A/S »

Kyverna Therapeutics shares owned by Novo A/S

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-03-31 $17M 700k 24.84

More positions owned by Novo A/S

Asml Holding N V N Y Registry Shs (ASML)
Brookfield Corp Cl A Ltd Vt Sh (BN)
salesforce (CRM)
Edgewell Pers Care (EPC)
Corcept Therapeutics Incorporated (CORT)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
Lanzatech Global (LNZA)
4d Molecular Therapeutics In (FDMT)
BioMarin Pharmaceutical (BMRN)
Mirum Pharmaceuticals (MIRM)
Insmed Com Par $.01 (INSM)
Alibaba Group Hldg Sponsored Ads (BABA)
Blueprint Medicines (BPMC)

View all positions for Novo A/S

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Rtw Investments
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Novo A/S
Millennium Management
Henderson Group
Wellington Management Company

View all funds holding Kyverna Therapeutics